Incline Equity Partners
12
10M
12
1.00
3
1
- Areas of investment
Summary
Incline Equity Partners appeared to be the VC, which was created in 2011. The venture was found in North America in United States. The leading representative office of defined VC is situated in the Pittsburgh.
The typical case for the fund is to invest in rounds with 1 participant. Despite the Incline Equity Partners, startups are often financed by SBRI Healthcare. In the next rounds fund is usually obtained by Halifax Group, GM&C Life Sciences Fund, China Medical Venture Investment (HK) Limited.
The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2015. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.
Among the most successful fund investment fields, there are Transportation, Pharmaceutical. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Blueberry Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United Kingdom.
Investments analytics
Analytics
- Total investments
- 12
- Lead investments
- 3
- Exits
- 1
- Rounds per year
- 1.00
- Investments by industry
- Manufacturing (4)
- Health Care (3)
- Service Industry (2)
- Medical (2)
- Retail (2) Show 17 more
- Investments by region
-
- United States (11)
- United Kingdom (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 36
- Avg. company exit year
- 89
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Blueberry Therapeutics | 08 Apr 2015 | Biotechnology, Health Care, Pharmaceutical | Seed | England, United Kingdom, United Kingdom |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.